WallStreetZenWallStreetZen

NASDAQ: NDRA
Endra Life Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NDRA

Based on 1 analyst offering 12 month price targets for Endra Life Sciences Inc

Min Forecast
$46.00+1,184.92%
Avg Forecast
$46.00+1,184.92%
Max Forecast
$46.00+1,184.92%

Should I buy or sell NDRA stock?

Based on 1 analyst offering ratings for Endra Life Sciences Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NDRA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates NDRA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their NDRA stock forecasts and price targets.

NDRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-30

1 of 1

Forecast return on equity

Is NDRA forecast to generate an efficient return?

Company
-421.23%
Industry
-0.11%
Market
55.96%
NDRA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NDRA forecast to generate an efficient return on assets?

Company
-232.88%
Industry
10.62%
NDRA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NDRA earnings per share forecast

What is NDRA's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$10.33
Avg 2 year Forecast
-$10.00

NDRA revenue forecast

What is NDRA's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$10.0k
Avg 2 year Forecast
$300.0k

NDRA vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NDRA$3.58$46.00+1,184.92%Buy
ISPC$0.94N/AN/A
APDN$4.83N/AN/A
MYNZ$1.38$14.00+914.49%Strong Buy
CHEK$0.77N/AN/A
View Top Diagnostic & Research Stocks

Endra Life Sciences Stock Forecast FAQ

Is Endra Life Sciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NDRA) stock is to Buy NDRA stock.

Out of 1 analyst, 0 (0%) are recommending NDRA as a Strong Buy, 1 (100%) are recommending NDRA as a Buy, 0 (0%) are recommending NDRA as a Hold, 0 (0%) are recommending NDRA as a Sell, and 0 (0%) are recommending NDRA as a Strong Sell.

If you're new to stock investing, here's how to buy Endra Life Sciences stock.

What is NDRA's earnings growth forecast for 2025-2026?

(NASDAQ: NDRA) Endra Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 41.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 56.75%.

Endra Life Sciences's earnings in 2025 is -$9,768,577.On average, 1 Wall Street analyst forecast NDRA's earnings for 2025 to be -$7,627,362, with the lowest NDRA earnings forecast at -$7,627,362, and the highest NDRA earnings forecast at -$7,627,362.

In 2026, NDRA is forecast to generate -$7,383,700 in earnings, with the lowest earnings forecast at -$7,383,700 and the highest earnings forecast at -$7,383,700.

What is NDRA's revenue growth forecast for 2025-2026?

(NASDAQ: NDRA) Endra Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 48.31%.

Endra Life Sciences's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast NDRA's revenue for 2025 to be $7,384, with the lowest NDRA revenue forecast at $7,384, and the highest NDRA revenue forecast at $7,384.

In 2026, NDRA is forecast to generate $221,511 in revenue, with the lowest revenue forecast at $221,511 and the highest revenue forecast at $221,511.

What is NDRA's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: NDRA) forecast ROA is -232.88%, which is lower than the forecast US Diagnostics & Research industry average of 10.62%.

What is NDRA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NDRA price target, the average NDRA price target is $46.00, with the highest NDRA stock price forecast at $46.00 and the lowest NDRA stock price forecast at $46.00.

The Wall Street analyst predicted that Endra Life Sciences's share price could reach $46.00 by May 30, 2026. The average Endra Life Sciences stock price prediction forecasts a potential upside of 1,184.92% from the current NDRA share price of $3.58.

What is NDRA's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: NDRA) Endra Life Sciences's current Earnings Per Share (EPS) is -$126.20. On average, analysts forecast that NDRA's EPS will be -$10.33 for 2025, with the lowest EPS forecast at -$10.33, and the highest EPS forecast at -$10.33. In 2026, NDRA's EPS is forecast to hit -$10.00 (min: -$10.00, max: -$10.00).

What is NDRA's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: NDRA) forecast ROE is -421.23%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.